Loading Events

Arizona Fall Learning Program

September 7, 2019
8:00 am CDT -12:00 pm CDT

Mayo Clinic Hospital
5777 E. Mayo Blvd.
Phoenix, AZ 85054 United States

Register

Join us for a complimentary educational event this fall, where you can network with colleagues, earn 3.5 CE contact hours, 0.6 pharma, and learn more about PCNA. Hosted by the Arizona PCNA Chapter.

PCNA members and non-members are welcome to register and attend. Please share this with colleagues and friends.

8:00 amWelcome, Breakfast, PCNA News
8:20 amPeripheral Arterial Disease: Risk Factors, Screening & Treatment
9:20 amDiabetes and the CV Nurse: A Stepwise Approach to Management
10:20 amBreak
10:30 amNational Guidelines for the Primary Prevention of CVD: Integrating Hypertension, Cholesterol, Diabetes, and Lifestyle Guidelines into Practice
12:00 pmClosing

Presentation Topics

Peripheral Arterial Disease: Risk Factors, Screening & Treatment (1 CE)

Learning Objectives

  • Outline the risk factors associated with PAD.
  • Describe the clinical presentation of patients with PAD.
  • List the steps to perform an Ankle Brachial Index (ABI) to screen for PAD.
  • Discuss common treatments for PAD including a supervised exercise training (SET) program for patients with claudication.

National Guidelines for the Primary Prevention of CVD: Integrating Hypertension, Cholesterol, Diabetes, and Lifestyle Guidelines into Practice (1.5 CE)

Learning Objectives

  • Review sources for National guidelines that relate to primary prevention of CVD and where to find them
  • Describe the identification and management of major CV risk factors utilizing current guideline recommendations
  • Explain how CV risk assessment tolls and patient-centered approaches can help to individualize risk factor management
  • Using a case study approach, apply current CVD prevention and risk reduction guidelines to patient care planning

Diabetes and the CV Nurse: A Stepwise Approach to Management (1.0 CE, 0.6 pharma)

Learning Objectives

  • Describe the association between diabetes and cardiovascular disease (CVD) and Chronic Kidney Disease (CKD).
  • Review ADA standards of care and CVD and CKD risk reduction.
  • Summarize clinical trial data supporting the use of antidiabetic therapy to improve CVD and CKD outcomes.
  • Explain a multidisciplinary, team-based approach to management of the patient with Type 2 Diabetes and the role of the CV clinician.